Corbus Pharmaceuticals Holding (CRBP) — Cash Flow-to-Debt Ratio
Corbus Pharmaceuticals Holding (CRBP) has a Cash Flow-to-Debt Ratio of -0.90x as of September 2025, meaning its operating cash flow of $-15.55 Million could theoretically repay -1% of its total liabilities ($17.37 Million) in one year. See Corbus Pharmaceuticals Holding free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Corbus Pharmaceuticals Holding Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Corbus Pharmaceuticals Holding across 13 annual periods. Also explore Corbus Pharmaceuticals Holding annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Corbus Pharmaceuticals Holding (2012–2024)
Year-by-year debt coverage analysis for Corbus Pharmaceuticals Holding. For market capitalisation and broader financial context, see how much is Corbus Pharmaceuticals Holding worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.11x | $-41.79 Million | $13.45 Million | ▼ -202.8% |
| 2023 | -1.03x | $-36.10 Million | $35.18 Million | ▲ +8.9% |
| 2022 | -1.13x | $-37.54 Million | $33.32 Million | ▲ +9.7% |
| 2021 | -1.25x | $-48.18 Million | $38.62 Million | ▲ +28.6% |
| 2020 | -1.75x | $-99.69 Million | $57.02 Million | ▼ -64.4% |
| 2019 | -1.06x | $-45.72 Million | $42.98 Million | ▲ +31.1% |
| 2018 | -1.54x | $-30.07 Million | $19.47 Million | ▲ +48.9% |
| 2017 | -3.02x | $-27.80 Million | $9.19 Million | ▼ -99.8% |
| 2016 | -1.51x | $-13.57 Million | $8.97 Million | ▼ -26.7% |
| 2015 | -1.19x | $-4.65 Million | $3.89 Million | ▲ +62.7% |
| 2014 | -3.20x | $-2.36 Million | $738.04K | ▼ -1722.3% |
| 2013 | -0.18x | $-366.71K | $2.09 Million | ▲ +83.0% |
| 2012 | -1.04x | $-769.73 | $743.36 | — |